Publications



 

  1. M. Ahmad, C. Dawson, S.P. Gan, R. Pathmanathan, V.K. Kumar, P.V.H. Lim, G. Selvaratnam, L.M. Looi, A.S.B. Khoo, P.G. Murray, C.C. Ng, S.H. Teo and L.F. Yap. An oncogenic role for Four-Jointed Box 1 (FJX1) in EBV-associated nasopharyngeal carcinoma. (Submitted)
  2. S.J. Chai, K.C. Pua, A. Saleh, Y.Y. Yap, P.V.H. Lim, S.K. Subramaniam, C.L. Lum, G. Krishnan, W.R. Wan Mahiyuddin, the Malaysian NPC Study Group, S.H. Teo, A.S.B. Khoo and L.F. Yap. Clinical significance of plasma Epstein-Barr virus DNA loads in a large cohort of Malaysian patients with nasopharyngeal carcinoma. J Clin Virol (2012), http://dx.doi.org/10.1016/j.jcv.2012.05.017
  3. P.Y Yew, T. Mushiroda, K. Kiyotani, G.K. Govindasamy, L.F. Yap, S.H. Teo, P.V. Lim, S. Govindaraju, K. Ratnavelu, C.K. Sam, Y.Y. Yap, A.S Khoo, K.C Pua, Y. Nakamura, The Malaysian NPC Study Group, C.C. Ng. Identification of a functional variant in SPLUNC1 associated with nasopharyngeal carcinoma susceptibility among Malaysian Chinese. Molecular Carcinogenesis (2011) doi: 10.1002/mc.21857 [Epub ahead of print].
  4. L.F. Yap, A. Munirah, M.M. Zabidi, S.J. Chai, T.L. Chu, S.K. Tan, W. Wei, P.G. Murray, S.H. Teo, A.S.B. Khoo. Wnt5A acts as an oncogene in EBV-associated nasopharyngeal carcinoma. European Journal of Cancer Supplements (2010) 8(5): 195.
  5. L.F. Yap, V. Jenei, C.M. Robinson, K. Moutasim, T.M. Benn, S.P. Threadgold, V. Lopes, W. Wei, G.J. Thomas, I.C. Paterson. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Oncogene (2009) 28(27):2524-34.
  6. S. Bose*, L.F. Yap*, M. Fung, J. Starzcynski, A. Saleh, S. Morgan, C.W. Dawson, M.B. Chukwuma, E. Maina, M. Buettner, W. Wei, J. Arrand, P.V.H. Lim, L.S. Young, S.H. Teo, T. Stankovic, C.B.J. Woodman and P.G. Murray. The ATM tumor suppressor gene is downregulated in EBV-associated nasopharyngeal carcinoma. J Pathol (2009) 217: 345-352 (*equal contribution).
  7. C.C. Ng, P.Y. Yew, S.M. Puah, G. Krishnan, L.F. Yap, S.H. Teo, P.V. Lim, S. Govindaraju, K. Ratnavelu, C.K. Sam, A. Takahashi, M. Kubo, N. Kamatani, Y. Nakamura, T. Mushiroda. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet (2009) 54(7):392-7.
  8. K.R.N. Baumforth, A. Birgersdotter, G.M. Reynolds, W. Wei, G. Kapatai, J.R. Flavell, E. Kalk, K. Piper, S. Lee, L. Machado, K. Hadley, A. Sundblad, J. Sjoberg, M. Bjorkholm, A.A. Porwit, L.F. Yap, S.H. Teo, R.G. Grundy, L.S. Young, I. Ernberg, C.B.J. Woodman and P.G. Murray. Expression of the Epstein-Bar virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates up-regulation of CCL20 and the migration of regulatory T cells. Am J Pathol (2008) 173(1):195-204.
  9. K.C. Pua, A.S.B Khoo, Y.Y. Yap, S.K. Subramaniam, C.A Ong, G. Gopala Krishnan, H. Shahid, The Malaysian NPC Study Group. Nasopharyngeal carcinoma database. Malaysian Nasopharyngeal Study Group. Med J Malaysia. 63 (2008) (Suppl C): 59-62.(S.H. Teo and L.F. Yap are members of The Malaysian Nasopharyngeal Study Group).
Patent:
1.      A method for the assessment of cancer in a biological sample obtained from a subject. Patent number: WO/2010/147452. Filed on 10th June 2010.